Opens in a new tab

COVID and Flu Test: Which One to Take as Both Viruses Rise This November

Table of Content

COVID and flu test at home: a woman checks a rapid nasal swab test cassette at her kitchen table in autumn

⚕️ This article is for informational purposes only and does not replace medical advice. Always consult your doctor to interpret your results.

Two respiratory viruses are climbing at the same time this November. CDC flu data for the week ending November 7, 2026, show that more than 11% of respiratory samples tested in clinical labs were positive for influenza, a level CDC calls higher than usual for this time of year, with the H1N1 strain causing almost all cases. In parallel, COVID-19 levels in wastewater have been rising for several weeks, and CDC forecasts show infections growing or likely growing in most states. With Thanksgiving gatherings days away, millions of people with a sore throat, fever or cough are asking the same question: should I take a COVID test, a flu test, or a combo test?

This article explains what each test can and cannot tell you, why a negative home test is not the end of the story, and when blood tests come into play. For the basics of the disease itself, see our guide to influenza symptoms and treatment.

What is new this November

Flu season started early and fast. According to CDC's FluView report published November 13, 2026, the share of positive flu tests in clinical labs reached 11.3% in week 44, outpatient visits for flu-like illness were above the national baseline, and A(H1N1)pdm09 accounted for nearly all subtyped influenza A viruses. CDC still rates the overall severity of the season as low for now, but warns this can change as activity increases.

COVID-19 is rising at the same time. CDC's national wastewater data showed a moderate level of viral activity in early November, with very high levels in several states including Florida, Virginia, Kentucky and Massachusetts, as reported by independent trackers that follow CDC dashboards. Because the two infections cause very similar symptoms in the first days, testing is the only reliable way to tell them apart.

COVID test, flu test or combo test: what each one does

All the tests below look for the virus itself in a nasal swab. They do not measure antibodies and they do not tell you whether you are immune.

TestWhereResult timeStrengthsLimits
Home COVID antigen testHome, pharmacy15 to 30 minutesA positive result is reliableOne negative result cannot rule out infection; repeat testing is needed
Home COVID and flu combo testHome, pharmacy15 to 30 minutes for mostChecks both viruses with one swabAntigen versions can miss many flu infections; molecular versions are more sensitive
PCR or other NAATLab, clinic, some pharmaciesMinutes (rapid systems) to 3 daysCDC calls it the gold standard; detects lower amounts of virusCan stay positive after you are no longer contagious
Multiplex respiratory panelUrgent care, emergency room, hospitalAbout 1 hour to 1 dayLooks for COVID, flu A and B, RSV and other viruses at onceUsually reserved for people who are sick enough to need care

Why one negative home test is not enough

A home antigen test only turns positive when there is enough virus in your nose. Early in the illness, the amount can still be too low. That is why CDC states that a single negative antigen test cannot rule out infection, and why the FDA recommends that people with symptoms test twice over three days, about 48 hours apart, and that people without symptoms test three times over five days. A negative test followed by a positive one two days later is a common pattern, not a faulty kit.

For flu, the gap is wider. Several combo antigen tests detect COVID-19 reasonably well but miss a large share of influenza cases in real-life use. If you test negative for flu at home but have a sudden high fever, body aches and exhaustion during a strong flu season, your clinician may still treat you as having flu, or confirm it with a molecular test.

When the result changes what you do

Testing early matters most for people at higher risk of complications: adults 65 and older, pregnant people, young children, and anyone with asthma, diabetes, heart disease, kidney disease, obesity or a weakened immune system. For them, a positive result can open the door to antiviral treatment. CDC notes that flu antivirals work best when started within two days after symptoms begin, and that COVID-19 treatment also needs to be started within a few days. Calling a clinician on day one is better than waiting to see whether the fever goes away.

For everyone, a positive result is a reason to avoid visiting older relatives or newborns, to wear a mask around others, and to postpone a holiday visit to someone who is frail. The flu shot remains the best prevention: see our article on who should get the 2026 flu shot.

Which tests can monitor or screen for this?

Swab tests identify the virus. Blood tests answer different questions, usually when the illness is lasting longer than expected or getting worse:

  • A complete blood count looks at white blood cells. Viral infections often lower some white cells or shift the balance toward lymphocytes, while bacterial infections often raise neutrophils.
  • C-reactive protein (CRP) measures inflammation. A very high value after several days of illness can point toward a bacterial complication such as pneumonia.
  • Procalcitonin rises mainly in bacterial infections and helps doctors decide whether antibiotics are useful. Our article on the new blood test that separates bacterial from viral infections explains how these markers are evolving.
  • Oxygen saturation, kidney function and blood sugar may be checked in people with chronic conditions, because flu and COVID-19 can unbalance diabetes or heart failure.

If symptoms persist for weeks after COVID-19, our article on tests studied in long COVID describes what researchers are looking at.

Recent scientific advances

Recent studies have refined how home tests should be used. A large community study published in 2024 in The Journal of Infectious Diseases compared rapid antigen tests with laboratory molecular tests and found that a single antigen test missed a large share of infections, especially in the first day of symptoms, while repeating the test after a negative result clearly improved detection. In practice, this supports the "test, then test again" advice now printed on most kits.

Combo tests are also better understood. A 2025 trial in British primary care (RAPTOR-C19) found that a combined COVID and flu antigen test was very specific, meaning a positive result could be trusted, but detected only a minority of flu infections confirmed by PCR. Manufacturer studies performed in controlled settings, such as a 2024 evaluation of a COVID and flu A and B panel, report much better results, which shows how much accuracy can drop between the lab bench and everyday use. For readers, the message is simple: a positive combo test is useful, a negative flu result is weak evidence, and molecular tests remain the reference when the answer changes treatment.

When to see a doctor

  • Trouble breathing, chest pain or pressure, bluish lips, confusion, or inability to stay awake: call 911.
  • Fever that comes back after improving, or a cough that worsens after several days: possible bacterial complication.
  • Any positive test, or strong symptoms during the flu season, if you are 65 or older, pregnant, or living with a chronic disease: contact a clinician the same day to discuss antivirals.
  • Signs of dehydration, especially in young children and older adults.

Glossary

  • Antigen test: a rapid test that detects viral proteins in a nasal swab.
  • NAAT: nucleic acid amplification test, a molecular test such as PCR that detects the genetic material of the virus.
  • Combo test: a single test that looks for COVID-19 and influenza A and B, sometimes RSV, from the same swab.
  • Serial testing: repeating a test at set intervals, usually 48 hours apart, after a negative result.
  • Sensitivity: the ability of a test to detect people who truly have the infection.
  • Specificity: the ability of a test to give a negative result in people who are not infected.
  • Wastewater surveillance: measurement of virus levels in sewage to follow community spread.

FAQ

Can a home test tell COVID from flu?

Yes, if you use a combo test that reads both viruses. A positive result for either is reliable, but a negative flu result can be wrong, especially early in the illness.

When is the best time to take a COVID test?

As soon as symptoms start, then again 48 hours later if the first test is negative. Without symptoms after an exposure, the FDA advises three tests over five days.

Is a PCR test better than a rapid test?

PCR detects smaller amounts of virus and is the reference method. Rapid tests are faster and cheaper, and a positive rapid test is usually enough.

Do I need a blood test for flu or COVID?

Usually not. Blood tests such as CRP, procalcitonin or a complete blood count are used when symptoms are severe, last longer than expected, or suggest a bacterial complication.

Can I go to Thanksgiving dinner after a negative test?

If you have symptoms, one negative test is not enough. Repeat it after 48 hours and avoid close contact with frail relatives until you feel better.

Sources

Other articles

Understand your own blood test results with AI DiagMe

If your doctor ordered a complete blood count, CRP or procalcitonin during a respiratory infection, AI DiagMe explains each value in plain language, compares it with reference ranges and helps you prepare the right questions for your next appointment.

Editorial team

  • AI DiagMe

    Author

    The AI DiagMe team brings together physicians, clinical specialists, and medical editors. Our articles are written by health communication professionals and then reviewed and validated by the physicians of our scientific committee, composed of practicing hospital physicians in specialties such as hematology, endocrinology, and general medicine. Julien Priour, who leads the editorial mission, holds an MBA from HEC Paris and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). Each piece of content is based on current clinical guidelines and peer-reviewed medical publications.

    Email Website
  • Julien Priour

    Edited by

    Co-founder and CEO of AI DiagMe · Senior medical editor · HEC Paris graduate

    Julien Priour is a senior medical editor at AI DiagMe, where he oversees the editorial line and the fact-checking process. A graduate of HEC Paris, he has 3 years of experience in health publishing and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). He makes sure that every article follows current medical guidelines and is reviewed and validated by a physician from the scientific and ethics committee. He sets the sourcing standards (HAS, Ameli, INSERM…) and the review standards applied across the entire site.

    Email LinkedIn
  • Dr. Claude Tchonko

    Medically reviewed by

    Dr. Claude Tchonko is a hematologist, in practice since 2013, currently working at Clinique Mas de Rochet (Castelnau-le-Lez, France). With an international background, he specializes in the management of hematologic malignancies (leukemias, lymphomas, myelomas), with particular expertise in autologous stem cell transplantation, CAR-T cell therapy and the optimization of care pathways in onco-hematology.

    Author of a reference work, “Lymphoid Hematologic Malignancies in Mali”, he combines clinical practice with active involvement in projects developing technology solutions for healthcare.

    He holds a State Doctorate in Medicine (Faculty of Medicine of Bamako, 2006) and completed his training with a Certificate of Specialized Studies in Bioclinical Hematology (Abidjan-Cocody, 2010) and several university diplomas: a DFMS in Hematology and an inter-university diploma (DIU) in Onco-Hematological Cytogenetics (Grenoble), as well as a university diploma (DU) in major sickle cell disease (UPEC).

    Dr. Claude Tchonko LinkedIn

Related Posts

Coming Soon